Content area
Abstract
[...]boost volumes should be small and targeted. [...]it is necessary that patients are empowered to exercise choices that reflect their individual preferences. RJ is funded by the Susan G Komen Foundation and has received grants paid to her institution for unrelated work from the National Institutes of Health, the Doris Duke Foundation, the Greenwall Foundation, the American Cancer Society, and Blue Cross Blue Shield of Michigan for the Michigan Radiation Oncology Quality Consortium; was principal investigator on a contract to conduct an investigator-initiated study with Genentech on the financial toxicity experienced by patients with breast cancer, paid to her institution; received personal fees for an advisory or grant review service from the National Institutes of Health, the Doris Duke Foundation, and the Greenwall Foundation; served as an expert witness for Sherinian and Hasso, Dressman Benzinger LaVelle, and Kleinbard, unrelated to the topic of this Comment; and has stock options as compensation for her advisory board role in Equity Quotient, a company that evaluates culture in health-care companies unrelated to the topic of this Comment.
Details
1 Department of Oncology, University of Cambridge, Cambridge CB2 0QQ, UK
2 Tata Medical Centre, Kolkata, India
3 Department of Radiation Oncology and Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, MI, USA
4 Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK